Altinova Alev Eroglu, Ozkan Cigdem, Akturk Mujde, Gulbahar Ozlem, Yalcin Muhittin, Cakir Nuri, Toruner Fusun Balos
Department of Endocrinology and Metabolism, Gazi University Faculty of Medicine, Besevler, 06500, Ankara, Turkey.
Department of Biochemistry, Gazi University Faculty of Medicine, Ankara, Turkey.
Endocrine. 2016 May;52(2):374-9. doi: 10.1007/s12020-015-0789-1. Epub 2015 Nov 7.
Free 25-hydroxyvitamin D [25(OH)D] is suggested to be important in the determination of vitamin D deficiency, since vitamin D-binding protein (VDBP) may affect total 25(OH)D levels. There are no data about free 25(OH)D concentrations in acromegaly. We aimed to investigate serum VDBP and total and free 25(OH)D levels in patients with acromegaly in comparison with control subjects. We recruited 54 patients with acromegaly and 32 control subjects who were similar according to age, gender, and body mass index. Serum VDBP levels were found to be increased in patients with acromegaly compared to control subjects [90.35 (72.45-111.10) vs. 69.52 (63.89-80.13) mg/l, p = 0.001]. There was statistically no significant difference in serum total 25(OH)D levels between the patients with acromegaly and control subjects [18.63 (13.35-27.73) vs. 22.51 (19.20-28.96) ng/ml, p = 0.05]. Free 25(OH)D levels were significantly decreased in patients with acromegaly compared to control subjects [14.55 (10.45-21.45) vs. 17.75 (15.30-23.75) pg/ml, p = 0.03]. Free 25(OH)D levels correlated positively with total 25(OH)D (p = 0.0001) and HDL cholesterol (p = 0.04) and negatively with fasting blood glucose (p = 0.04). Our findings indicate that VDBP is increased and free 25(OH)D is decreased in acromegaly, while there is no significant alteration in total 25(OH)D.
游离25-羟基维生素D[25(OH)D]被认为在维生素D缺乏的判定中很重要,因为维生素D结合蛋白(VDBP)可能会影响总25(OH)D水平。目前尚无关于肢端肥大症患者游离25(OH)D浓度的数据。我们旨在调查肢端肥大症患者与对照者的血清VDBP以及总25(OH)D和游离25(OH)D水平。我们招募了54例肢端肥大症患者和32名对照者,这些对照者在年龄、性别和体重指数方面与患者相似。结果发现,与对照者相比,肢端肥大症患者的血清VDBP水平升高[90.35(72.45 - 111.10)对69.52(63.89 - 80.13)mg/l,p = 0.001]。肢端肥大症患者与对照者之间的血清总25(OH)D水平在统计学上无显著差异[18.63(13.35 - 27.73)对22.51(19.20 - 28.96)ng/ml,p = 0.05]。与对照者相比,肢端肥大症患者的游离25(OH)D水平显著降低[14.55(10.4S-21.45)对17.75(15.30 - 23.75)pg/ml,p = 0.03]。游离25(OH)D水平与总25(OH)D呈正相关(p = 0.0001),与高密度脂蛋白胆固醇呈正相关(p = 0.04),与空腹血糖呈负相关(p = 0.04)。我们的研究结果表明,肢端肥大症患者的VDBP升高而游离25(OH)D降低,而总25(OH)D无显著变化。